DK1627631T3 - Morfinsulfatmikrogranuler, fremgangsmåde til fremstilling deraf og præparat omfattende samme - Google Patents

Morfinsulfatmikrogranuler, fremgangsmåde til fremstilling deraf og præparat omfattende samme

Info

Publication number
DK1627631T3
DK1627631T3 DK05111290.2T DK05111290T DK1627631T3 DK 1627631 T3 DK1627631 T3 DK 1627631T3 DK 05111290 T DK05111290 T DK 05111290T DK 1627631 T3 DK1627631 T3 DK 1627631T3
Authority
DK
Denmark
Prior art keywords
preparation
same
morphine sulfate
sulfate microgranules
microgranules
Prior art date
Application number
DK05111290.2T
Other languages
Danish (da)
English (en)
Inventor
Dominique Marechal
Pascal Oury
Pascal Suplie
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9546553&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1627631(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Application granted granted Critical
Publication of DK1627631T3 publication Critical patent/DK1627631T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK05111290.2T 1999-06-09 2000-06-08 Morfinsulfatmikrogranuler, fremgangsmåde til fremstilling deraf og præparat omfattende samme DK1627631T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9907259A FR2794646B1 (fr) 1999-06-09 1999-06-09 Microgranules de sulfate de morphine, procede de preparation et composition les contenant
EP00940460A EP1189602B1 (fr) 1999-06-09 2000-06-08 Microgranules de sulfate de morphine, procede de preparation et composition les contenant

Publications (1)

Publication Number Publication Date
DK1627631T3 true DK1627631T3 (da) 2012-04-30

Family

ID=9546553

Family Applications (2)

Application Number Title Priority Date Filing Date
DK05111290.2T DK1627631T3 (da) 1999-06-09 2000-06-08 Morfinsulfatmikrogranuler, fremgangsmåde til fremstilling deraf og præparat omfattende samme
DK00940460T DK1189602T3 (da) 1999-06-09 2000-06-08 Morfinmikrogranula, fremgangsmåde til fremstilling og præparat der indeholder dem

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK00940460T DK1189602T3 (da) 1999-06-09 2000-06-08 Morfinmikrogranula, fremgangsmåde til fremstilling og præparat der indeholder dem

Country Status (24)

Country Link
US (2) US7063864B1 (enExample)
EP (3) EP1627631B1 (enExample)
JP (1) JP4296562B2 (enExample)
KR (1) KR100676123B1 (enExample)
CN (1) CN1267089C (enExample)
AR (2) AR024313A1 (enExample)
AT (2) ATE544448T1 (enExample)
AU (1) AU769160C (enExample)
BR (1) BRPI0011404B8 (enExample)
CA (1) CA2376339C (enExample)
CO (1) CO5160317A1 (enExample)
CY (1) CY1107612T1 (enExample)
DE (1) DE60033519T2 (enExample)
DK (2) DK1627631T3 (enExample)
ES (2) ES2280226T3 (enExample)
FR (1) FR2794646B1 (enExample)
HK (1) HK1045107B (enExample)
MX (1) MXPA01012751A (enExample)
NZ (1) NZ516077A (enExample)
PT (2) PT1627631E (enExample)
SI (1) SI1189602T1 (enExample)
TW (1) TWI224510B (enExample)
WO (1) WO2000074659A1 (enExample)
ZA (1) ZA200110087B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2794646B1 (fr) * 1999-06-09 2001-09-21 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de preparation et composition les contenant
JP4848101B2 (ja) * 2001-08-17 2011-12-28 株式会社フジモト・コーポレーション 徐放性マイクロペレット
US20040253310A1 (en) 2001-09-21 2004-12-16 Gina Fischer Morphine polymer release system
WO2003024429A1 (en) 2001-09-21 2003-03-27 Egalet A/S Polymer release system
EP1610767B1 (en) 2003-03-26 2011-01-19 Egalet A/S Morphine controlled release system
FR2883179B1 (fr) * 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
US20070286900A1 (en) * 2006-06-09 2007-12-13 Catherine Herry Low dose tablets of opioid analgesics and preparation process
US20100233257A1 (en) * 2006-06-09 2010-09-16 Ethypharm Low dose sublingual tablets of opioid analgesics and preparation process
WO2008148798A2 (en) 2007-06-04 2008-12-11 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
CA2751667C (en) 2009-02-06 2016-12-13 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
EP2445487A2 (en) 2009-06-24 2012-05-02 Egalet Ltd. Controlled release formulations
US20190038769A1 (en) * 2010-12-01 2019-02-07 Gowey Research Group, Pllc Micro-rna profiling, compositions, and methods of treating diseases
JP2012250926A (ja) * 2011-06-01 2012-12-20 Nitto Denko Corp 粒子製剤
MX2014015880A (es) 2012-07-06 2015-08-05 Egalet Ltd Composiciones farmaceuticas disuasivas de abuso para liberacion controlada.
EP3727384A4 (en) 2017-12-20 2021-11-03 Purdue Pharma L.P. ABUSE-DISSUASIVE MORPHINE SULPHATE FORMES

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8514665D0 (en) 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
CA2007181C (en) * 1989-01-06 1998-11-24 Angelo Mario Morella Sustained release pharmaceutical composition
US5133974A (en) 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
GB9119958D0 (en) 1991-09-18 1991-10-30 Unilever Plc Detergent compositions
US5286493A (en) 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
SE9301057L (sv) 1993-03-30 1994-10-01 Pharmacia Ab Beredning med kontrollerad frisättning
EP1442745A1 (en) * 1993-10-07 2004-08-04 Euro-Celtique Orally administrable opioid formulations having extended duration of effect
US5411745A (en) 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
US5460826A (en) 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
FR2771291B1 (fr) 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
FR2794646B1 (fr) * 1999-06-09 2001-09-21 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de preparation et composition les contenant

Also Published As

Publication number Publication date
CO5160317A1 (es) 2002-05-30
ATE544448T1 (de) 2012-02-15
HK1045107B (zh) 2007-05-11
AU769160C (en) 2006-02-23
WO2000074659A1 (fr) 2000-12-14
ES2379688T3 (es) 2012-04-30
CN1267089C (zh) 2006-08-02
US7063864B1 (en) 2006-06-20
BRPI0011404B8 (pt) 2021-05-25
AR068015A2 (es) 2009-10-28
JP2003520770A (ja) 2003-07-08
PT1189602E (pt) 2007-05-31
KR20020031338A (ko) 2002-05-01
CA2376339C (fr) 2011-05-17
FR2794646B1 (fr) 2001-09-21
EP1189602A1 (fr) 2002-03-27
EP1189602B1 (fr) 2007-02-21
DK1189602T3 (da) 2007-07-02
EP1627631A2 (fr) 2006-02-22
MXPA01012751A (es) 2002-07-02
AU769160B2 (en) 2004-01-15
DE60033519D1 (de) 2007-04-05
ES2280226T3 (es) 2007-09-16
ATE354356T1 (de) 2007-03-15
CA2376339A1 (fr) 2000-12-14
BR0011404A (pt) 2002-03-05
EP1818051A1 (fr) 2007-08-15
PT1627631E (pt) 2012-05-21
US20070003620A1 (en) 2007-01-04
NZ516077A (en) 2004-06-25
FR2794646A1 (fr) 2000-12-15
EP1627631A3 (fr) 2006-03-15
CN1390121A (zh) 2003-01-08
HK1045107A1 (en) 2002-11-15
ZA200110087B (en) 2003-03-03
BR0011404B1 (pt) 2013-03-05
KR100676123B1 (ko) 2007-01-31
EP1627631B1 (fr) 2012-02-08
JP4296562B2 (ja) 2009-07-15
DE60033519T2 (de) 2007-10-31
AU5539400A (en) 2000-12-28
CY1107612T1 (el) 2013-03-13
AR024313A1 (es) 2002-09-25
TWI224510B (en) 2004-12-01
SI1189602T1 (sl) 2007-06-30

Similar Documents

Publication Publication Date Title
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
NO20021449D0 (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
PT1177178E (pt) Benzimidazois hetereciclicos substituidos, sua preparacao e aplicacao
PL347885A1 (en) Azepinoindole derivatives, the production and use thereof
HUP0203225A3 (en) Benzodiazepin derivatives, the production and use thereof
MXPA01012104A (es) Electrocatalizador de rodio y metodos de preparacion.
IS5353A (is) Asýl-píperasínil-pýrimídínafleiður, framleiðsla og notkun þeirra sem lyfja
DK1261697T3 (da) Kuldeaktiv beta-galactosidase, fremgangsmåde til fremstilling heraf og anvendelsen deraf
DK1627631T3 (da) Morfinsulfatmikrogranuler, fremgangsmåde til fremstilling deraf og præparat omfattende samme
DE69942040D1 (de) Sensorvorrichtung und dessen herstellungsverfahren.
NO20022834L (no) Zeolitt SSZ-50, fremgangsmåte for fremstilling og anvendelse av denne
IL161893A0 (en) 5-Phenylpyrimidines, agents comprising the same, method for production and use thereof
DK1054672T3 (da) Morfinsulfatmikrogranula, fremgangsmåde til fremstilling deraf og farmaceutiske præparater
TR199801871A3 (tr) Bifenilsulfonilsiyanamidler üretim yöntemi ve ilaç olarak kullanimlari.
EG24350A (en) Prilling method
EP1537083A4 (en) S - (-) - AMLODIPINNICOTINATE AND METHOD FOR THE PRODUCTION THEREOF
PL354994A1 (en) Bio-supportive matrices, methods of making and using the same
MXPA01011720A (es) 3-piridil-4-arilpirroles sustituidos, y metodos terapeuticos y profilacticos relacionados.
AU2796602A (en) Coniosetin and derivatives thereof, method for producing the same and use thereof
DK1192163T3 (da) Dithiepino[6,5-b]pyriner, beslægtede præparater og fremgangsmåder
NO991111D0 (no) Nytt ensileringsmiddel, fremgangsmÕte for fremstilling av dette ensileringsmiddelet og bruk av dette
IL157793A0 (en) Caloporoside derivatives, methods for the production thereof and their use
HUP0201690A3 (en) Novel antifungal agents and fungicides, method for the production thereof and their use
MXPA03004632A (es) Klainetina y sus derivados, metodo para su produccion y su uso.